Fatal Subarachnoid Haemorrhage in Young Women:Role of Oral Contraceptives
BMJ 283:762, Thorogood,M.,et al, 1981
Benign Coital Cephalalgia
Arch Neurol 38:710-712, Porter,M.,et al, 1981
Memory Enhancement in Korsakoff's Psychosis by Clonidine:Evid. of a Noradrenergic Deficit
Ann Neurol 7:466-470, McEntee,W.J.,et al, 1980
Epilepsy & Pregnancy
Editorial, BMJ 281:1087-10881980., , 1980
The Prolactinoma Problem
NEJM 300:313-315, Reichlin,S., 1979
Chorea Induced by Oral Contraceptives
Neurol 29:1605-1609, Nausieda,A.,et al, 1979
Autonomic Epilepsy:Clonidine Blockade of Paroxysmal Catecholamine Release & Flushing
Ann Int Med 88:189, Metz,S.A.,et al, 1978
Primary Cerebral Venous Thrombosis in Young Adults:The Diverse Mmanifestations of an Underrecognized Disease
Ann Neurol 3:81, Averbak,P., 1978
Newer Concepts in Management of Migraine Headaches
J Med Soc N J 74:11, Haidri,N.H.,et al, 1977
Galactorrhea:A Study of 235 Cases, Including 48 with Pituitary Tumors
NEJM 296:589, Kleinberg,D.L.,et al, 1977
Dynamic Radionuclide Scanning in the Diagnosis of Thrombosis of the Superior Sagittal Sinus
Neurol 27:656, Barner,B.D.,et al, 1977
Fibromuscular Dysplasia of Intracranial Arteries in a Patient with Multiple Enchondromas (Ollier disease)
Neurol 27:1168, Slagsvold,J.E.,et al, 1977
Superior Sagittal Sinus Thrombosis
Arch Neurol 34:2, Gettelfinger,D.M.,et al, 1977
Case Records of the MassGeneral Hospital, Case 41-1975, Acute Intermittent Porphyria
NEJM 293:817, Woods,B., 1975
Oral Contraceptives & Stroke in Young Women-Collaborative Group
JAMA 231:718, , 1975
Oral Contraception & Increased Risk of Cerebral Ischemia or Thrombosis-Collaborative Group
NEJM 288:871, 906, 1973, Corr 289:219, 1973, 289:809., , 1973
Lupus Erythematosus
Arch Derm 106:553, Tuffanelli,D., 1972
Drug-Induced Movement Disorders
Postgrad Med 180, 1971, Sept., North,R., 1971
Stroke, Sickle Cell Trait, & Oral Contraceptives
Ann Int Med (letter) 72:960970., Greenwald,J.G., 1970
Dural Sinus & Cerebral Venous Thrombus
Arch Neurol 22:440, Buchanan,D.S., 1970
Thromboembolic Disease & Oral Contraceptives in Women
Letter from HEW Jan 12, , 1970
Nonatherosclerotic Causes of Stroke
Ann Int Med 70:807, Levine,J.,et al, 1969
Nonatherosclerotic Causes of Stroke
Ann Int Med 70:807, Levine,J.,et al, 1969
Case Records of MGH
NEJM 280:1009, 1969 Systemic Lupus Erythematosus with Necrotizing Angiitis., , 1969
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025
Severe Myotonic Crisis Resembling Malignant Hyperthermia
Neurol 104:e213497, Wadhwani,A.R.,et al, 2025
Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025
Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025
Parkinsons Disease
NEJM 391:442-452, Tanner,C.M. & Ostrem,J.L., 2024
Clinical Presentation, Management, and Outcome in Neurolymphomatosis, A Systematic Review
Neurol 103:e209698, Kaulen.L.D.,et al, 2024
Comparative Effects of Drug Interventions for the Acute Management of Migraine Episodes in Adults:Systematic Review and Network Meta-Analysis
BMJ 386:e080107, Karlsson,W.K.,et al, 2024
Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine, A Phase 4, Randomized, Placebo-Controlled Trial
JAMA Neurol 81:1140-1149, Tepper,S.J.,et al, 2024
Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024
Diagnosis and Management of ANCA-Associated Vasculitis
Lancet 403:683-698, Kronbichler, A., et al, 2024
Lecanemab for Alzheimer Disease, Is It Worth It?
Neurol 102:e209265, Nelson,S.E. & Lopez,O.L., 2024
Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA 330:512-517, 510, Sims,J.R.,et al, 2023
Polymyalgia Rheumatica
Lancet 402:1459-1472, Espigol-Frigole,G.,et al, 2023
Severe Amyloid-Related Imaging Abnormalities After Anti-B-Amyloid Monoclonal Antibody Treatment
Neurol 101:1079-1080, Bonami,S.,et al, 2023
Lecanemab in Early Alzheimers Disease
NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023
Cutaneous a-Synuclein Signatures in Patients with MultipleSystem Atrophy and Parkinson Disease
Neurol 100:e1529-e1539, Gibbons,C.,et al, 2023
Neuroimaging Biomarkers in a Patient with Probable Psychiatric-Onset Prodromal Dementia with Lewy Bodies
Neurol 99:654-657, Urso, D.,et al, 2022
Neuromyelitis Optica Spectrum Disorder
NEJM 387:631-639, Wingerchuk, D.M. & Lucchinetti, C.F., 2022
Clinicopathologic Conference, Encephalitis due to Behcets Disease
NEJM 387:925-933, Case 27-2022, 2022
Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings
Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021
Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
Aducanumab: What About the Patient?
Ann Neurol 90:334-335, Petersen, R.C., 2021
Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors
Neurol 97:e191-e202, Nersesjan, V.,et al, 2021
Progressive Multifocal Leukoencephalopathy in a Patient with Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy
JAMA Neurol 78:736-740, Patel,A.,et al, 2021
Relapse of Severe Neurosarcoidosis with Switch from Originator Infliximab to Biosimilar
Neurol 94:991-993, Kidd, D.P.,et al, 2020